Cuprina Holdings [Cayman] Limited (CUPR)

$0.56 -0.04 (-5.98%)
Market Cap 12.47M
Revenue (ttm) 48,321.00
Net Income (ttm) -1.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,229.52%
Debt to Equity Ratio 0.00
Volume 110,000
Avg Vol 147,830
Day's Range N/A - N/A
Shares Out 21.00M
Stochastic %K 6%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the va...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 65 8512 7275
Address:
Blk 1090, Lower Delta Road #06-08, Singapore, Singapore
F74
F74 Dec. 11 at 3:40 PM
$CUPR big scam
0 · Reply
Antc888
Antc888 Dec. 11 at 10:28 AM
$CUPR this junk dilute 1% daily.
0 · Reply
AlienTrador
AlienTrador Dec. 10 at 10:17 PM
$CUPR this POS LITERALLY bankrupted me. Reminds me of $HMNY and $ECEZ which both destroyed me. There will be a class action law suit here too.
0 · Reply
AlienTrador
AlienTrador Dec. 10 at 5:31 PM
$CUPR this is dead
1 · Reply
F74
F74 Dec. 10 at 4:13 PM
$CUPR ammasso di merda ! delinquenti
0 · Reply
Heidne
Heidne Dec. 10 at 8:55 AM
$CUPR Total revenue in 2026 is projected at $1.0 to $1.5 million, said Mr. Quek. “We look forward to our most successful year yet in 2026. Our team is energized to deliver sustainable value for our patients, our partners, and our shareholders." For further information on Cuprina’s financial results for the first six months of 2025, please see its 6-K SEC filing at http://www.sec.gov or on the investor relations section of the Company’s website at https://investors.cuprina.com/financial-information#filings.
1 · Reply
davidwolf0
davidwolf0 Dec. 9 at 10:50 PM
$CUPR I miss the time when Chinese stocks exploded..
0 · Reply
AlienTrador
AlienTrador Dec. 9 at 6:25 PM
$CUPR this is a nightmare
0 · Reply
Aguilar97
Aguilar97 Dec. 9 at 4:44 PM
$CUPR good luck everyone I sold hopefully it spikes but this company is just awful at how they operate
0 · Reply
Aguilar97
Aguilar97 Dec. 9 at 3:58 PM
$CUPR to hold or not to hold with looming delisting notice would this company release anything of value to bring the price over $1
0 · Reply
Latest News on CUPR
Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Nov 28, 2025, 8:30 AM EST - 13 days ago

Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies

Oct 27, 2025, 8:40 AM EDT - 6 weeks ago

Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies

Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET

Oct 6, 2025, 8:30 AM EDT - 2 months ago

Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET

Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology

Sep 9, 2025, 8:05 AM EDT - 3 months ago

Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology

Are You Holding These 6 Potential Pump-And-Dump Stocks? The Bear Cave Sees These As The Next Targets

Aug 11, 2025, 12:28 PM EDT - 4 months ago

Are You Holding These 6 Potential Pump-And-Dump Stocks? The Bear Cave Sees These As The Next Targets

EPSM FLYE MIMI PTHL QMMM STFS

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market

Jul 21, 2025, 9:00 AM EDT - 5 months ago

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market

Cuprina Provides Update on Research Studies with Three Leading Education Institutes

Jun 30, 2025, 8:00 AM EDT - 5 months ago

Cuprina Provides Update on Research Studies with Three Leading Education Institutes

Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries

Jun 4, 2025, 8:00 AM EDT - 6 months ago

Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries

Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering

May 8, 2025, 1:05 PM EDT - 7 months ago

Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering

Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.

May 5, 2025, 12:29 PM EDT - 7 months ago

Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

May 5, 2025, 12:27 PM EDT - 7 months ago

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering

May 5, 2025, 12:24 PM EDT - 7 months ago

Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering

U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility

Apr 12, 2025, 1:30 AM EDT - 8 months ago

U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility

AIRO ATHR CHA CIIT FATN IOTR MB

Singapore-based Cuprina Holdings, which makes wound care products, files for a $10 million US IPO

Mar 7, 2024, 9:55 PM EST - 1 year ago

Singapore-based Cuprina Holdings, which makes wound care products, files for a $10 million US IPO

Cuprina Holdings IPO Registration Document (F-1)

Mar 7, 2024, 4:09 PM EST - 1 year ago

Cuprina Holdings IPO Registration Document (F-1)

F74
F74 Dec. 11 at 3:40 PM
$CUPR big scam
0 · Reply
Antc888
Antc888 Dec. 11 at 10:28 AM
$CUPR this junk dilute 1% daily.
0 · Reply
AlienTrador
AlienTrador Dec. 10 at 10:17 PM
$CUPR this POS LITERALLY bankrupted me. Reminds me of $HMNY and $ECEZ which both destroyed me. There will be a class action law suit here too.
0 · Reply
AlienTrador
AlienTrador Dec. 10 at 5:31 PM
$CUPR this is dead
1 · Reply
F74
F74 Dec. 10 at 4:13 PM
$CUPR ammasso di merda ! delinquenti
0 · Reply
Heidne
Heidne Dec. 10 at 8:55 AM
$CUPR Total revenue in 2026 is projected at $1.0 to $1.5 million, said Mr. Quek. “We look forward to our most successful year yet in 2026. Our team is energized to deliver sustainable value for our patients, our partners, and our shareholders." For further information on Cuprina’s financial results for the first six months of 2025, please see its 6-K SEC filing at http://www.sec.gov or on the investor relations section of the Company’s website at https://investors.cuprina.com/financial-information#filings.
1 · Reply
davidwolf0
davidwolf0 Dec. 9 at 10:50 PM
$CUPR I miss the time when Chinese stocks exploded..
0 · Reply
AlienTrador
AlienTrador Dec. 9 at 6:25 PM
$CUPR this is a nightmare
0 · Reply
Aguilar97
Aguilar97 Dec. 9 at 4:44 PM
$CUPR good luck everyone I sold hopefully it spikes but this company is just awful at how they operate
0 · Reply
Aguilar97
Aguilar97 Dec. 9 at 3:58 PM
$CUPR to hold or not to hold with looming delisting notice would this company release anything of value to bring the price over $1
0 · Reply
Heidne
Heidne Dec. 9 at 3:17 PM
$CUPR https://www.linkedin.com/posts/skyline-corporate-communications-group-llc_cuprina-cupr-biotech-activity-7404171735765299200-UDM2?utm_source=share&utm_medium=member_ios&rcm=ACoAAB8J6doBjrZteH3hc27hfKDzdcGbS_6Mj-E
1 · Reply
AlienTrador
AlienTrador Dec. 9 at 3:16 PM
$CUPR sell-off now
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Dec. 9 at 3:15 PM
$CUPR so? What shall markets do with it? Trust in them and run it up for '26 boost or slide it further w/ zero volume? Would love a run up of course, but there are no metrics fitting here. So a pre-sales essentially and 1.2M '26 if all good -> P/S 3 -> 3.6M or 16c? What shall the metrics be to have folks investing?
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Dec. 9 at 3:07 PM
$CUPR to be fair, alarm bells ring with this: revenue "down 40% ... in the prior-year period, primarily due to lower sales of both the Company’s cosmeceutical and MEDIFLY MDT products." Besides the low cash (again).
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Dec. 9 at 3:02 PM
$CUPR let's call it a rough IPO start *cough cough*, balance sheet 4.9M prepayment spend from ~11M IPO cash (prepayments, what exactly?) and some 3M+ left. ~22M shares, 6M equity (includes 4.9M prepayment). Outlook: From 18k 1H25 revs to 1M - 1.5M for 2026(!) ? That is tough! So the Saudi license shall come in SOON to actually move the needle and fill the cash coffers? However - they did deliver the ER and all other items so far.
0 · Reply
SkylineCCG
SkylineCCG Dec. 9 at 2:55 PM
Skyline Corporate Communications Group shares an update from our client, Cuprina Wound Care Solutions $CUPR , following the Company’s announcement of financial results for the six months ended June 30, 2025, and its strategic initiatives aimed at driving 2026 growth. Cuprina, a biomedical company operating across chronic wound care, infertility treatments, medical waste recycling, and cosmeceuticals, reported a period of increased investment and accelerated development. A key milestone was the completion and ISO 13485 certification of Cuprina’s new IVF media production facility in Singapore. The site is now licensed and preparing for regulatory submission, with commercial sales expected to begin upon approval—projected for the fourth quarter of 2026. 🔗 Read more here: https://www.globenewswire.com/news-release/2025/12/09/3202369/0/en/Cuprina-Holdings-Cayman-Limited-Announces-Financial-Results-for-the-Six-Months-Ended-June-30-2025-and-Strategic-Initiatives-for-2026-Growth.html Skyline is paid by $CUPR for IR services. Disclaimer 17(b): https://skylineccg.com/disclosures/
0 · Reply
Aguilar97
Aguilar97 Dec. 9 at 2:04 PM
$CUPR earnings are out
2 · Reply